12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Other News

Boehringer Ingelheim, Bristol-Myers infectious news

The Medicines Patent Pool said it began negotiations for patents to HIV drugs from Boehringer and Bristol-Myers. The pool, established last year by UNITAID, allows companies to obtain a license to market generic versions of patented HIV/AIDS drugs in developing countries. Boehringer markets HIV drugs...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >